Differences in Real-World Health and Economic Outcomes Among Patients with COPD Treated with Combination Tiotropium/Olodaterol Versus Triple Therapy.

Palli SR, Frazer M, DuCharme M, Buikema AR, Anderson AJ, Franchino-Elder J

Open source

DOI
10.18553/jmcp.2020.20159
Published
2020 Oct
Container
Journal of managed care & specialty pharmacy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.18553/jmcp.2020.20159,
  title = {Differences in Real-World Health and Economic Outcomes Among Patients with COPD Treated with Combination Tiotropium/Olodaterol Versus Triple Therapy.},
  author = {Palli SR and Frazer M and DuCharme M and Buikema AR and Anderson AJ and Franchino-Elder J},
  year = {2020},
  journal = {Journal of managed care \& specialty pharmacy},
  doi = {10.18553/jmcp.2020.20159},
  url = {https://doi.org/10.18553/jmcp.2020.20159}
}

RIS

TY  - JOUR
TI  - Differences in Real-World Health and Economic Outcomes Among Patients with COPD Treated with Combination Tiotropium/Olodaterol Versus Triple Therapy.
AU  - Palli SR
AU  - Frazer M
AU  - DuCharme M
AU  - Buikema AR
AU  - Anderson AJ
AU  - Franchino-Elder J
PY  - 2020
JO  - Journal of managed care & specialty pharmacy
DO  - 10.18553/jmcp.2020.20159
UR  - https://doi.org/10.18553/jmcp.2020.20159
ER  - 

APA

SR, P., M, F., M, D., AR, B., AJ, A., & J, F. (2020). Differences in Real-World Health and Economic Outcomes Among Patients with COPD Treated with Combination Tiotropium/Olodaterol Versus Triple Therapy.. Journal of managed care & specialty pharmacy. https://doi.org/10.18553/jmcp.2020.20159

Source records